Navigation Links
Anti-allergy vaccine based on 'hygiene hypothesis'

A new vaccine has been developed that could obliterate common allergies like asthma, pollen and hayfever that afflict millions of people.//

The ‘hygiene hypothesis’ suggests that allergies may occur indirectly due to too much cleanliness as it deprives the immune system of a proper training against germs that have lived with humans for millions of years. As a result, the body begins to produce reactions against harmless substances like grass pollen.

This theory was exploited by a Swiss-based Cytos Biotechnology company to develop an anti-allergy drug that makes the immune system to focus on mycobacteria. This drug called CYT003 – QbG10 activates the immune system to attack potentially larger threats like mycobacteria, a group of bacteria found in soil and water that are come across rarely these days due to modern cleanliness. In this manner, the immune system is deceived and made to forget the allergens and look for bigger threats.

A study was conducted on 10 people with hay fever. It was found that there was a 100-fold reduction in the patient’s sensitivity to grass pollen after a 6-weeks course of injections.
A previous study reveals drug’s efficacy against house dust mite allergy. The patients were without any symptoms for one year when the drug was given along with doses of the allergen.
The researchers used a DNA strand that imitates mycobacteria’s genetic material. This DNA is packed into a fake virus particle and delivered into the body. This is taken up by the immune system.

The company is currently testing the drug in over 100 people with hay fever, house dust mite allergy, and allergic dermatitis. The results are expected to be out in the first half of 2007.

'"/>




Page: 1

Related medicine news :

1. New hope for cancer victims – will vaccine cure the deadly bug
2. New vaccine helps allergy and asthma patients
3. Man against HIV – new vaccine ready for human trials
4. New vaccine helps allergy and asthma patients
5. Development of AIDS vaccine -- Chiron Corp in talks with four Indian cos
6. HIV did not arise from polio vaccine
7. Double impact vaccine
8. High Demand for a child vaccine
9. A new vaccine for leukemia
10. Shortage of MMR vaccine
11. Anthrax vaccine produced
Post Your Comments:
(Date:10/10/2008)...Michigan received $5 million from the National Ins...esource of high-quality experimental data sets of ...mputer-aided drug design to a new level. , The ...puter programs that can predict the effectiveness ...ciate professor in the U-M College of Pharmacy and...
(Date:10/10/2008)... Johns Hopkins University School,of Medicine is la...ptimizing Adjuvant Breast Cancer Strategies: From ...ent key research data on the latest advances in,br...ents in the treatment of breast cancer have,led to...ons that are,increasingly tailored to the specific...
(Date:10/10/2008)... The Mobile Massage Team, (http://www.mobilemassag...massage,services for corporate wellness programs, ... today that it is expanding its service area throu...lphia metropolitan region., "We are quite excited...ed, massage programs and services throughout both...
(Date:10/10/2008)...nationally recognized faculty will,present the ver...east,cancer in the multimedia course "Optimizing A...to Treatment Selection" during National Breast,Can...icing oncologists and other interested,health care...t care,advances. This accredited course offers con...
Breaking Medicine News(10 mins):Health News:U-M to house leading drug database 2Health News:Latest Research on Breast Cancer Presented in a Virtual E-Conference CME Course 2Health News:Mobile Massage Team Announces Expansion of On-Site Seated Massage Services Throughout Eastern Pennsylvania and the Greater Philadelphia Region 2Health News:Nationally Recognized Faculty Presents Latest Advances in Care of Patients with Breast Cancer 2
...racterized by insulin resistance and/or abnormal i... continues to expand unabated throughout the world...d // to decreased physical activity, decreased fun...index, preexisting glucose and insulin abnormaliti...
... most common breathing problems encountered by man...as been a considerable increase in the incidence o...has been estimated that nearly 196,000 children ar...ery year with asthma attacks. A considerable amoun...
...at skin cancer could actually be caused as a resul... has been reported after scientists have worked to...g gene chip array technology. The technology allo...nes at once, helping to pinpoint the role played b...
...s of the type A, including those causing seasonal ...bile and well adapted to elude host defenses. The ...and permanent antigenic changes necessitates const...and annual adjustments in the composition of influ...
Other Medicine News:Health News:Cigarette Smoking Leads To Development Of Type 2 Diabetes In Patients With Coronary Artery Disease 2Health News:Improved parent-physician communication to prevent hospitalizations for childhood asthma 2Health News:A Vaccine for the impending pandemic Avian Influenza 2
(Date:10/10/2008).../ -- TriReme Medical Inc. (TMI),announced today th...ite,Europeenne) marking and commercialize in Europ...main vessel stent system specially designed for us... the next generation in bifurcation stenting, the,...of the 2.2 million,angioplasty procedures performe...
(Date:10/9/2008)...d to protect the eyesight of,older people, NEW YO...e worldwide who,are blind, 80 percent are over age... their blindness if they had been properly diagnos...se, go to:, http://www.prnewswire.com/mnr/orbis/35...ucts and equipment, is,partnering with nonprofit O...
(Date:10/9/2008)...ovember 2008, BOTHELL, Wash., Oct. 9 /PRNewswire-...ounced today the completion of patient enrollment ...ls to evaluate the safety and,efficacy of its form... for,the over-the-counter (OTC) market. The Compan...otal trial in November 2008. Ibuprofen is an analg...
(Date:10/9/2008)...all/ -- Diamyd Medical reports,that the world,s mo...urnal,of Medicine, has published an article with r...iabetes vaccine for type 1 diabetes., (Logo: htt...), The article is now available on the journal,s ...int on October 30. It presents the,results of the ...
Breaking Medicine Technology:TriReme Medical Inc. Receives CE Marking for Antares(TM) Coronary Stent System 2ORBIS and Alcon Call Attention to the Aging Eye 2ORBIS and Alcon Call Attention to the Aging Eye 3SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 2SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 3Diamyd(R) Study Published in Prestigious New England Journal of Medicine 2Diamyd(R) Study Published in Prestigious New England Journal of Medicine 3Diamyd(R) Study Published in Prestigious New England Journal of Medicine 4Groundbreaking Canada US study proves link between emissions and mercury pollution in fish 430 1Los Angeles Area Chamber of Commerce Endorses Governor Schwarzeneggers Health Care Proposal 1437 1Los Angeles Area Chamber of Commerce Endorses Governor Schwarzeneggers Health Care Proposal 1437 2Health IT Now 21 Coalition Urges Congress to Pass Health Information Technology Bill This Year 1433 1Health IT Now 21 Coalition Urges Congress to Pass Health Information Technology Bill This Year 1433 2Health IT Now 21 Coalition Urges Congress to Pass Health Information Technology Bill This Year 1433 3Cardiome to Present at ThinkEquity Conference 1429 1Cardiome to Present at ThinkEquity Conference 1429 2Cardiome to Present at ThinkEquity Conference 1429 3
...O, Calif., April 03, 2007,/PRNewswire-FirstCall/ -...d results from its second multi-center Phase 2 tri... evaluated escalating doses,of the immunotherapy i...rostate cancer (HRPC). Additional follow-up of,the...ble to that,being employed in the company,s ongoin...
...ting of the European Association for the Study,of ...wire/ -- Pharmasset,announced today that presentat...reatment of hepatitis B (HBV) and PSI-6130, the,pa...itis C (HCV),will be made during the 42nd Annual M...f the Liver (EASL) being held in,Barcelona, Spain ...
Other Medicine Technology:Cell Genesys Provides Final Median Survival Data From Second Phase,2 Trial of GVAX Immunotherapy for Prostate Cancer 2Cell Genesys Provides Final Median Survival Data From Second Phase,2 Trial of GVAX Immunotherapy for Prostate Cancer 3Pharmasset Announces Clevudine and Hepatitis C Presentations at,EASL 2Pharmasset Announces Clevudine and Hepatitis C Presentations at,EASL 3Pharmasset Announces Clevudine and Hepatitis C Presentations at,EASL 4
... The many benefits of fibre bronchoscopy: The HF-c...ich all other fibre bronchoscopes are measured., ...rom PENTAX, including the FB-19TV, FB-18V and FB-1...pediatric FB-8V, offer much better image quality t...
... The many benefits of fibre bronchoscopy: The HF-c...ich all other fibre bronchoscopes are measured., ...rom PENTAX, including the FB-19TV, FB-18V and FB-1...pediatric FB-8V, offer much better image quality t...
Fujinon's therapeutic fiberoptic bronchoscopes offers a generous 2.6mm operating channel with a slim outside diameter. The large channel allows for improved suction and easier passage of cytology bru
... High performance fiberoptic imaging from the late...roved its fiberscope range, focussing on providing...ced image performance. Olympus has a impressive ra...erapy in the respiratory tract to meet the demands...
Medicine Products: